Health

India’s Cipla says supply of COVID-19 drug remdesivir catching…

By Manas Mishra (Reuters) – India’s Cipla said on Saturday that its manufacturing of the COVID-19 remdesivir drug was beginning to catch up with...
Ketelo Backar
1 min read

Amid India COVID-19 crisis, remembering the people: Reporter’s Notebook

On the ground in India, COVID-19 is everywhere. It’s in the fear that keeps people trapped indoors, a vacant silence falling over the normally...
Ketelo Backar
3 min read

Success story Taiwan faces its worst outbreak in pandemic

TAIPEI, Taiwan (AP) — The island of Taiwan, which has had enviable success in containing COVID-19, imposed new restrictions in its capital city on...
Ketelo Backar
51 sec read

India’s daily COVID-19 deaths near 4,000 as WHO flags…

By Manas Mishra and Swati Bhat MUMBAI (Reuters) – India reported a smaller rise in daily coronavirus infections on Saturday, but deaths stayed near...
Ketelo Backar
1 min read

Why did Yankees test positive after vaccination?

NEW YORK (AP) — A New York Yankees player and several team staffers tested positive for the coronavirus although they were vaccinated, the baseball...
Ketelo Backar
1 min read

Body camera footage shows ‘horrific’ in-custody death of Black…

The Department of Justice is investigating the death of a Black man with a mental illness at a South Carolina jail, as newly released...
Ketelo Backar
4 min read

Mainland China reports 14 new COVID-19 cases vs 7…

SHANGHAI (Reuters) – Mainland China reported 14 new COVID-19 cases on May 14, up from seven cases a day earlier, the country’s national health...
Ketelo Backar
30 sec read

A lab leak in Wuhan remains a ‘viable’ theory…

A year-and-a-half into the pandemic, experts are still arguing over the coronavirus’ mysterious origins. An international group of scientists has come forward to say...
Ketelo Backar
3 min read

What it’s like giving birth in your 20s versus…

In 2016, for the first time ever, more American women had babies in their early 30s than in their 20s. Giving birth at any...
Ketelo Backar
2 min read